This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy.

About us

Company Overview

Founders and Leadership Team

History

Research and Development

Pipeline

Discovery Research

Clinical Development

Pharmaceutical R&D

Quality System

Investor Relationship

Partnering

News Release

Company News

Media Report

Industrial News

Careers

中



News Release

> News Release

> Company News

Company News

Media Report

Industrial News

Hope Medicine announced global license agreement with Bayer AG to advance the development and commercialization of the monoclonal antibody directed against prolactin (PRL) receptor

Top